Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: June 2014


Suggested reading

Besag FM, Berry DJ, Pool F. Methsuximide lowers lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction. Epilepsia 2000; 41: 624–627.
Browne TR, Feldman RG, Buchanan RA, Allan NC, Fawcett-Vickers L, Szako GK, Mattson GF, Norman SE, Greenblatt DJ. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology 1983; 33: 414–418.
Hurst DL. The use of methsuximide for juvenile myoclonic epilepsy. Annals of Neurology 1995; 38: 517.
Strong JM, Abe T, Gibbs EL, Atkinson AJ. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy. Neurology 1974; 24: 250–255.
Tennison MB, Greenwood RS, Miles MV. Methsuximide for intractable childhood seizures. Pediatrics 1991; 87: 186–189.
Wilder BJ, Buchanan RA. Methsuximide for refractory complex partial seizures. Neurology 1981; 31: 741–744.